Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • MD,
  • DM,
  • FRCP,
  • FAMS

  • Introducing the International Home Dialysis Consortium

    Kidney International Reports Date published:

  • A community-based intervention to improve screening, referral, and follow-up of non-communicable diseases and anaemia amongst pregnant and postpartum women in rural India: study protocol for a cluster randomised trial

    Unknown Date published:

  • Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group

    Kidney International Date published:

  • The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease

    Kidney International Date published:

  • Perspectives on early detection of chronic kidney disease: the facts, the questions, and a proposed framework for 2023 and beyond

    Kidney International Date published:

  • Climate Change, Heat-Related Acute Kidney Disease, and the Need for Action

    American Journal of Kidney Diseases Date published:

  • Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

    Journal of Human Hypertension Date published:

  • Urinary exosomal miRNA-663a shows variable expression in diabetic kidney disease patients with or without proteinuria

    Scientific Reports Date published:

  • PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

    Trials Date published:

  • Community acquired and hospital acquired AKI - two diseases divided by a common definition

    Current Opinion in Nephrology & Hypertension Date published:

  • India’s latest essential medicines list: gaps, strengths and opportunities in evidence-based decision-making

    BMJ Evidence-Based Medicine Date published:

  • National health policies and strategies for addressing chronic kidney disease: Data from the International Society of Nephrology Global Kidney Health Atlas

    PLOS Global Public Health Date published:

  • Complementary medicine and phospholipase A2 receptor (PLA2R)-related membranous nephropathy-fortuitous or causal?

    Kidney International Date published:

  • Personalized Treatment of PLA2R-Related Membranous Nephropathy

    Clinical Journal of the American Society of Nephrology Date published:

  • PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

    Unknown Date published: